Symbols / EDAP Stock $3.22 -2.57% EDAP TMS S.A.

Healthcare • Medical Distribution • France • NGM
EDAP (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Distribution
CEO Mr. Ryan Rhodes
Exch · Country NGM · France
Market Cap 120.69M
Enterprise Value 127.99M
Income -29.25M
Sales 70.53M
FCF (ttm) -12.13M
Book/sh 0.52
Cash/sh 0.55
Employees —
Insider 10d —
IPO Aug 01, 1997
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -5.75
PEG —
P/S 1.71
P/B 6.22
P/C —
EV/EBITDA -6.01
EV/Sales 1.81
Quick Ratio 1.16
Current Ratio 1.54
Debt/Eq 142.93
LT Debt/Eq —
EPS (ttm) -0.78
EPS next Y -0.56
EPS Growth —
Revenue Growth -19.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-03-25
ROA -18.33%
ROE -94.50%
ROIC —
Gross Margin 42.54%
Oper. Margin -26.17%
Profit Margin -41.47%
Shs Outstand 37.48M
Shs Float 28.53M
Insider Own 9.85%
Instit Own 38.98%
Short Float 0.24%
Short Ratio 1.18
Short Interest 37.92K
52W High 5.05
vs 52W High -36.24%
52W Low 1.21
vs 52W Low 166.12%
Beta -0.08
Impl. Vol. 12.50%
Rel Volume 0.12
Avg Volume 51.90K
Volume 6.13K
Target (mean) $5.50
Tgt Median $4.00
Tgt Low $2.50
Tgt High $10.00
# Analysts 3
Recom None
Prev Close $3.31
Price $3.22
Change -2.57%
About

EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales channels, and third-party distributors and agents. The company serves academic, public, and private hospitals, as well as clinics. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Vaulx-en-Velin, France.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$5.50
Mean price target
2. Current target
$3.22
Latest analyst target
3. DCF / Fair value
$-5.83
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.22
Low
$2.50
High
$10.00
Mean
$5.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-09 main HC Wainwright & Co. Buy → Buy $10
2025-04-04 down Jefferies Buy → Hold $2
2025-03-28 main Piper Sandler Overweight → Overweight $5
2025-03-28 reit HC Wainwright & Co. Buy → Buy $19
2024-08-29 reit HC Wainwright & Co. Buy → Buy $19
2024-07-22 reit HC Wainwright & Co. Buy → Buy $19
2024-05-17 reit HC Wainwright & Co. Buy → Buy $19
2024-04-01 main HC Wainwright & Co. Buy → Buy $19
2023-11-10 main Piper Sandler Overweight → Overweight $9
2023-08-25 reit HC Wainwright & Co. Buy → Buy $16
2023-05-18 main Lake Street — → Buy $16
2023-05-01 main Lake Street Buy → Buy $14
2023-04-13 main HC Wainwright & Co. — → Buy $16
2023-02-15 main HC Wainwright & Co. — → Buy $13
2022-12-06 main Lake Street — → Buy $14
2022-11-18 main HC Wainwright & Co. — → Buy $12
2022-11-01 init Jefferies — → Buy $11
2021-11-19 main HC Wainwright & Co. — → Buy $11
2021-04-28 init Piper Sandler — → Overweight $13
2021-04-01 main HC Wainwright & Co. — → Buy $12
News
RSS: Latest EDAP news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
70.53
+1.63%
69.40
+3.90%
66.79
+13.02%
59.10
Operating Revenue
70.53
+1.63%
69.40
+3.90%
66.79
+13.02%
59.10
Cost Of Revenue
40.53
-0.31%
40.65
+2.12%
39.81
+20.07%
33.15
Reconciled Cost Of Revenue
40.53
-0.31%
40.65
+2.12%
39.81
+20.07%
33.15
Gross Profit
30.00
+4.37%
28.74
+6.52%
26.98
+4.01%
25.94
Operating Expense
54.70
+7.31%
50.97
+4.26%
48.88
+60.22%
30.51
Research And Development
9.66
+15.52%
8.36
+8.65%
7.70
+45.88%
5.28
Selling General And Administration
45.03
+5.70%
42.61
+3.44%
41.19
+63.22%
25.23
Selling And Marketing Expense
27.32
-0.18%
27.36
+9.40%
25.01
+42.39%
17.56
General And Administrative Expense
17.72
+16.25%
15.24
-5.77%
16.18
+110.91%
7.67
Other Gand A
17.72
+16.25%
15.24
-5.77%
16.18
+110.91%
7.67
Total Expenses
95.22
+3.93%
91.62
+3.30%
88.69
+39.31%
63.66
Operating Income
-24.70
-11.11%
-22.23
-1.48%
-21.90
-379.61%
-4.57
Total Operating Income As Reported
-24.69
-11.11%
-22.23
-1.48%
-21.90
-379.74%
-4.57
EBITDA
-24.61
-42.78%
-17.24
+15.19%
-20.33
-5768.07%
-0.35
Normalized EBITDA
-21.04
-13.18%
-18.59
-1.36%
-18.34
-660.65%
-2.41
Reconciled Depreciation
3.41
+22.69%
2.78
+31.32%
2.11
+22.86%
1.72
EBIT
-28.02
-39.99%
-20.02
+10.81%
-22.44
-985.36%
-2.07
Total Unusual Items
-3.58
-365.36%
1.35
+167.79%
-1.99
-196.33%
2.06
Total Unusual Items Excluding Goodwill
-3.58
-365.36%
1.35
+167.79%
-1.99
-196.33%
2.06
Special Income Charges
—
—
0.00
0.00
Other Special Charges
—
—
—
—
Net Income
-29.25
-42.08%
-20.58
+12.07%
-23.41
-644.28%
-3.15
Pretax Income
-28.81
-42.11%
-20.27
+10.69%
-22.70
-909.78%
-2.25
Net Non Operating Interest Income Expense
-0.54
-188.76%
0.60
-49.28%
1.19
+371.27%
0.25
Interest Expense Non Operating
0.79
+208.20%
0.26
-0.18%
0.26
+42.35%
0.18
Net Interest Income
-0.54
-188.76%
0.60
-49.28%
1.19
+371.27%
0.25
Interest Expense
0.79
+208.20%
0.26
-0.18%
0.26
+42.35%
0.18
Interest Income Non Operating
0.25
-70.73%
0.86
-40.59%
1.45
+234.49%
0.43
Interest Income
0.25
-70.73%
0.86
-40.59%
1.45
+234.49%
0.43
Other Income Expense
-3.58
-365.36%
1.35
+167.79%
-1.99
-196.33%
2.06
Gain On Sale Of Security
-3.58
-365.36%
1.35
+167.79%
-1.99
-196.33%
2.06
Tax Provision
0.44
+39.94%
0.31
-56.03%
0.71
-20.69%
0.90
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-0.89
-365.36%
0.34
+167.79%
-0.50
-196.33%
0.52
Net Income Including Noncontrolling Interests
-29.25
-42.08%
-20.58
+12.07%
-23.41
-644.25%
-3.15
Net Income From Continuing Operation Net Minority Interest
-29.25
-42.08%
-20.58
+12.07%
-23.41
-644.28%
-3.15
Net Income From Continuing And Discontinued Operation
-29.25
-42.08%
-20.58
+12.07%
-23.41
-644.28%
-3.15
Net Income Continuous Operations
-29.25
-42.08%
-20.58
+12.07%
-23.41
-644.25%
-3.15
Normalized Income
-26.56
-23.01%
-21.59
+1.48%
-21.92
-366.99%
-4.69
Net Income Common Stockholders
-29.25
-42.08%
-20.58
+12.07%
-23.41
-644.28%
-3.15
Diluted EPS
-0.78
-46.98%
-0.53
+15.77%
-0.63
-552.82%
-0.10
Basic EPS
-0.78
-46.98%
-0.53
+15.77%
-0.63
-552.82%
-0.10
Basic Average Shares
37.44
+0.42%
37.29
+0.78%
37.00
+7.57%
34.39
Diluted Average Shares
37.44
+0.42%
37.29
+0.78%
37.00
+7.57%
34.39
Diluted NI Availto Com Stockholders
-29.25
-42.08%
-20.58
+12.07%
-23.41
-644.28%
-3.15
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
79.00
-11.64%
89.41
-11.65%
101.20
-6.68%
108.44
Current Assets
57.16
-21.25%
72.59
-16.32%
86.75
-10.63%
97.07
Cash Cash Equivalents And Short Term Investments
20.45
-34.02%
31.00
-35.50%
48.05
-29.03%
67.71
Cash And Cash Equivalents
20.45
-34.02%
31.00
-35.50%
48.05
-29.03%
67.71
Receivables
22.58
+7.16%
21.08
-0.89%
21.27
+32.71%
16.02
Accounts Receivable
21.29
+9.77%
19.39
+2.08%
19.00
+36.64%
13.90
Receivables Adjustments Allowances
—
-0.39
-56.29%
-0.25
-43.41%
-0.17
Other Receivables
0.42
-69.37%
1.37
+1067.51%
0.12
+137.53%
0.05
Taxes Receivable
0.88
+128.31%
0.39
-72.66%
1.41
-10.97%
1.58
Inventory
12.83
-33.22%
19.21
+15.01%
16.70
+32.23%
12.63
Raw Materials
9.24
-35.62%
14.35
+44.68%
9.92
+22.62%
8.09
Work In Process
1.52
+43.25%
1.06
+87.11%
0.57
+86.49%
0.30
Finished Goods
3.56
-40.06%
5.94
-22.03%
7.62
+36.16%
5.59
Prepaid Assets
1.30
-0.61%
1.31
+79.42%
0.73
+2.92%
0.71
Other Current Assets
-0.00
+66.67%
-0.00
—
—
Total Non Current Assets
21.32
+30.82%
16.30
+12.85%
14.44
+27.00%
11.37
Net PPE
12.99
+27.11%
10.22
+12.88%
9.06
+41.09%
6.42
Gross PPE
26.97
+27.56%
21.14
+2.91%
20.54
+21.90%
16.85
Accumulated Depreciation
-13.97
-27.98%
-10.92
+4.95%
-11.49
-10.09%
-10.43
Machinery Furniture Equipment
7.74
+10.94%
6.97
-1.91%
7.11
+12.69%
6.31
Other Properties
19.23
+35.74%
14.16
+5.47%
13.43
+27.40%
10.54
Goodwill And Other Intangible Assets
4.63
+27.51%
3.63
-5.99%
3.86
+14.88%
3.36
Goodwill
2.83
+13.13%
2.50
-6.05%
2.67
+3.08%
2.59
Other Intangible Assets
1.80
+59.45%
1.13
-5.86%
1.20
+54.19%
0.78
Non Current Accounts Receivable
0.55
—
—
—
Non Current Deferred Assets
1.09
+26.47%
0.86
+7.34%
0.81
-9.36%
0.89
Non Current Deferred Taxes Assets
1.09
+26.47%
0.86
+7.34%
0.81
-9.36%
0.89
Non Current Prepaid Assets
—
—
—
—
Other Non Current Assets
2.06
+30.23%
1.58
+119.70%
0.72
+2.29%
0.70
Total Liabilities Net Minority Interest
59.58
+26.99%
46.92
+22.59%
38.27
+21.01%
31.63
Current Liabilities
37.14
-5.45%
39.28
+28.77%
30.50
+31.04%
23.28
Payables And Accrued Expenses
17.36
-7.78%
18.83
+7.27%
17.55
+52.42%
11.52
Payables
11.98
-8.53%
13.09
+4.14%
12.57
+70.75%
7.36
Accounts Payable
11.72
-10.15%
13.04
+5.03%
12.42
+74.42%
7.12
Other Payable
0.06
+10.71%
0.06
-16.95%
0.07
+798.25%
0.01
Current Accrued Expenses
5.39
-6.07%
5.74
+15.18%
4.98
+19.92%
4.15
Employee Benefits
2.32
-4.84%
2.44
-10.20%
2.71
+21.48%
2.23
Pensionand Other Post Retirement Benefit Plans Current
3.33
-0.72%
3.35
+18.65%
2.82
+12.16%
2.52
Total Tax Payable
0.19
+2512.50%
-0.01
-109.40%
0.09
-63.76%
0.23
Income Tax Payable
0.19
+2512.50%
-0.01
-109.40%
0.09
-63.76%
0.23
Current Debt And Capital Lease Obligation
9.35
-8.33%
10.20
+80.52%
5.65
+15.25%
4.90
Current Debt
8.11
-9.81%
8.99
+102.31%
4.44
+20.18%
3.70
Other Current Borrowings
8.11
-9.81%
8.99
+102.31%
4.44
+20.18%
3.70
Current Capital Lease Obligation
1.25
+2.64%
1.21
+0.40%
1.21
+0.15%
1.21
Current Deferred Liabilities
7.10
+2.88%
6.90
+54.14%
4.48
+3.05%
4.34
Current Deferred Revenue
7.10
+2.88%
6.90
+54.14%
4.48
+3.05%
4.34
Other Current Liabilities
—
-0.00
—
-0.00
Total Non Current Liabilities Net Minority Interest
22.44
+193.68%
7.64
-1.65%
7.77
-6.93%
8.35
Long Term Debt And Capital Lease Obligation
18.33
+330.35%
4.26
+16.36%
3.66
-29.02%
5.16
Long Term Debt
15.90
+608.06%
2.25
+1.74%
2.21
-42.61%
3.85
Long Term Capital Lease Obligation
2.43
+20.66%
2.01
+38.55%
1.45
+10.83%
1.31
Long Term Provisions
0.38
+216.67%
0.12
-30.41%
0.17
-1.35%
0.17
Non Current Pension And Other Postretirement Benefit Plans
—
2.18
-12.08%
2.48
+17.74%
2.10
Non Current Deferred Liabilities
1.41
+71.15%
0.82
-32.52%
1.22
+56.81%
0.78
Non Current Deferred Revenue
0.97
+159.68%
0.37
-47.66%
0.71
+151.06%
0.28
Other Non Current Liabilities
-0.00
-100.00%
-0.00
+9.53%
-0.00
-203.08%
0.00
Stockholders Equity
19.41
-54.31%
42.48
-32.48%
62.92
-18.09%
76.82
Common Stock Equity
19.41
-54.31%
42.48
-32.48%
62.92
-18.09%
76.82
Capital Stock
6.07
+0.21%
6.06
+12.97%
5.36
+4.70%
5.12
Common Stock
6.07
+0.21%
6.06
+12.97%
5.36
+4.70%
5.12
Share Issued
37.75
+0.24%
37.66
+0.77%
37.37
+0.47%
37.20
Ordinary Shares Number
37.48
+0.24%
37.39
+0.78%
37.10
+0.52%
36.91
Treasury Shares Number
0.27
+0.00%
0.27
+0.00%
0.27
-6.02%
0.29
Additional Paid In Capital
151.31
+1.71%
148.77
+11.31%
133.65
+9.37%
122.20
Retained Earnings
-128.62
-29.43%
-99.37
-41.46%
-70.25
-54.59%
-45.44
Gains Losses Not Affecting Retained Earnings
-8.34
+30.25%
-11.95
-140.97%
-4.96
-20.79%
-4.11
Treasury Stock
1.02
+0.00%
1.02
+15.23%
0.88
-8.07%
0.96
Total Equity Gross Minority Interest
19.41
-54.31%
42.48
-32.48%
62.92
-18.09%
76.82
Total Capitalization
35.32
-21.05%
44.73
-31.32%
65.13
-19.26%
80.66
Working Capital
20.02
-39.89%
33.31
-40.78%
56.25
-23.78%
73.79
Invested Capital
43.42
-19.17%
53.72
-22.79%
69.57
-17.53%
84.36
Total Debt
27.68
+91.44%
14.46
+55.30%
9.31
-7.45%
10.06
Net Debt
3.56
—
—
—
Capital Lease Obligations
3.67
+13.88%
3.23
+21.23%
2.66
+5.71%
2.52
Net Tangible Assets
14.78
-61.95%
38.85
-34.21%
59.06
-19.60%
73.45
Tangible Book Value
14.78
-61.95%
38.85
-34.21%
59.06
-19.60%
73.45
Inventories Adjustments Allowances
-1.48
+30.46%
-2.13
-52.85%
-1.40
-3.16%
-1.35
Non Current Accrued Expenses
—
—
—
—
Notes Receivable
—
0.32
-67.89%
0.99
+49.69%
0.66
Other Inventories
-0.00
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-16.41
-11.60%
-14.70
+9.38%
-16.23
-400.32%
-3.24
Cash Flow From Continuing Operating Activities
-16.41
-11.61%
-14.70
+9.39%
-16.23
-400.36%
-3.24
Net Income From Continuing Operations
-29.25
-42.08%
-20.58
+12.07%
-23.41
-644.28%
-3.15
Depreciation Amortization Depletion
3.41
+22.69%
2.78
+31.32%
2.11
+22.86%
1.72
Depreciation And Amortization
3.41
+22.69%
2.78
+31.32%
2.11
+22.86%
1.72
Other Non Cash Items
—
-0.00
-190.47%
0.00
-99.97%
4.22
Stock Based Compensation
2.56
-27.97%
3.55
-53.17%
7.59
+236.48%
2.26
Provisionand Write Offof Assets
0.78
-36.20%
1.22
+90.12%
0.64
+195.01%
0.22
Deferred Tax
-0.23
-120.00%
-0.10
-326.16%
0.05
-9.81%
0.05
Deferred Income Tax
-0.23
-120.00%
-0.10
-326.16%
0.05
-9.81%
0.05
Operating Gains Losses
3.39
+508.24%
0.56
+50379.47%
0.00
-99.61%
0.29
Gain Loss On Investment Securities
2.87
—
—
—
Change In Working Capital
2.93
+237.92%
-2.12
+33.84%
-3.21
+30.67%
-4.63
Change In Receivables
-0.57
-278.00%
-0.15
+97.24%
-5.43
-156.39%
-2.12
Change In Inventory
6.85
+256.58%
-4.37
+6.06%
-4.66
+3.13%
-4.81
Change In Payables And Accrued Expense
-3.43
-213.41%
3.02
-56.14%
6.89
+189.05%
2.38
Change In Accrued Expense
-0.46
-127.45%
1.68
+60.27%
1.05
-9.25%
1.16
Change In Payable
-2.96
-321.52%
1.34
-77.08%
5.84
+376.25%
1.23
Change In Other Current Assets
0.07
+111.61%
-0.62
-4574.02%
-0.01
+84.92%
-0.09
Investing Cash Flow
-5.71
-28.17%
-4.46
+7.14%
-4.80
-88.30%
-2.55
Cash Flow From Continuing Investing Activities
-5.72
-28.19%
-4.46
+7.16%
-4.80
-88.34%
-2.55
Net PPE Purchase And Sale
-1.21
+14.90%
-1.42
-9.19%
-1.30
-98.25%
-0.66
Purchase Of PPE
-1.21
+14.90%
-1.42
-9.19%
-1.30
-98.25%
-0.66
Sale Of PPE
—
—
0.00
0.00
Capital Expenditure
-5.76
-29.77%
-4.44
+6.54%
-4.75
-90.87%
-2.49
Capital Expenditure Reported
-3.72
-34.35%
-2.77
+3.13%
-2.86
-69.59%
-1.68
Net Investment Purchase And Sale
0.00
0.00
-100.00%
0.00
0.00
Purchase Of Investment
—
—
—
—
Sale Of Investment
0.00
0.00
-100.00%
0.00
0.00
Net Intangibles Purchase And Sale
-0.83
-234.14%
-0.25
+57.82%
-0.59
-301.78%
-0.15
Purchase Of Intangibles
-0.83
-234.14%
-0.25
+57.82%
-0.59
-301.78%
-0.15
Net Other Investing Changes
0.04
+309.52%
-0.02
+61.23%
-0.05
+12.92%
-0.06
Financing Cash Flow
8.61
+71.65%
5.02
+598.10%
-1.01
-104.32%
23.31
Cash Flow From Continuing Financing Activities
8.61
+71.62%
5.02
+598.20%
-1.01
-104.32%
23.32
Net Issuance Payments Of Debt
8.61
+76.00%
4.89
+477.61%
-1.30
-33.49%
-0.97
Issuance Of Debt
12.42
+343.75%
2.80
0.00
-100.00%
0.31
Repayment Of Debt
-2.92
-51.61%
-1.93
+4.59%
-2.02
-63.42%
-1.24
Long Term Debt Issuance
12.42
+343.75%
2.80
0.00
-100.00%
0.31
Long Term Debt Payments
-2.92
-51.61%
-1.93
+4.59%
-2.02
-63.42%
-1.24
Net Long Term Debt Issuance
9.49
+991.15%
0.87
+143.06%
-2.02
-117.33%
-0.93
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
-0.88
-121.95%
4.02
+454.65%
0.73
+1879.44%
-0.04
Net Common Stock Issuance
—
0.00
0.00
-100.00%
23.55
Proceeds From Stock Option Exercised
0.00
-100.00%
0.12
-56.67%
0.29
-60.90%
0.74
Net Other Financing Charges
—
-0.00
—
-0.00
Changes In Cash
-13.52
+4.45%
-14.14
+35.80%
-22.03
-225.74%
17.52
Effect Of Exchange Rate Changes
2.97
+202.70%
-2.89
-1076.89%
0.30
+171.20%
-0.42
Beginning Cash Position
31.00
-35.47%
48.03
-31.17%
69.79
+37.93%
50.60
End Cash Position
20.45
-34.02%
31.00
-35.50%
48.05
-29.03%
67.71
Free Cash Flow
-22.17
-15.81%
-19.14
+8.74%
-20.97
-265.98%
-5.73
Common Stock Issuance
—
0.00
0.00
-100.00%
23.55
Issuance Of Capital Stock
—
0.00
0.00
-100.00%
23.55
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category